These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25062462)

  • 1. Lack of FGF23 response to acute changes in serum calcium and PTH in humans.
    Wesseling-Perry K; Wang H; Elashoff R; Gales B; Jüppner H; Salusky IB
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1951-6. PubMed ID: 25062462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.
    Vervloet MG; van Ittersum FJ; Büttler RM; Heijboer AC; Blankenstein MA; ter Wee PM
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):383-9. PubMed ID: 21030580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men.
    Burnett-Bowie SM; Henao MP; Dere ME; Lee H; Leder BZ
    J Bone Miner Res; 2009 Oct; 24(10):1681-5. PubMed ID: 19419295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
    Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84).
    Wesseling-Perry K; Harkins GC; Wang HJ; Elashoff R; Gales B; Horwitz MJ; Stewart AF; Jüppner H; Salusky IB
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2772-80. PubMed ID: 20382692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.
    Grethen E; Hill KM; Jones R; Cacucci BM; Gupta CE; Acton A; Considine RV; Peacock M
    J Clin Endocrinol Metab; 2012 May; 97(5):1655-62. PubMed ID: 22362819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
    Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
    Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
    Iguchi A; Kazama JJ; Yamamoto S; Yoshita K; Watanabe Y; Iino N; Narita I
    Nephron; 2015; 131(3):161-6. PubMed ID: 26551233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD.
    Wetmore JB; Santos PW; Mahnken JD; Krebill R; Menard R; Gutta H; Quarles LD
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E57-64. PubMed ID: 20943782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study.
    Kim HJ; Kim H; Shin N; Na KY; Kim YL; Kim D; Chang JH; Song YR; Hwang YH; Kim YS; Ahn C; Lee J; Oh KH;
    BMC Nephrol; 2013 May; 14():112. PubMed ID: 23705925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.
    Gutiérrez OM; Smith KT; Barchi-Chung A; Patel NM; Isakova T; Wolf M
    Clin J Am Soc Nephrol; 2012 Jan; 7(1):139-45. PubMed ID: 22246283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
    Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M
    Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.
    Scialla JJ; Parekh RS; Eustace JA; Astor BC; Plantinga L; Jaar BG; Shafi T; Coresh J; Powe NR; Melamed ML
    Am J Nephrol; 2015; 42(1):25-34. PubMed ID: 26287973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
    Navarro JF; Mora C; Macia M; Garcia J
    Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency.
    Iguchi A; Yamamoto S; Yamazaki M; Tasaki K; Suzuki Y; Kazama JJ; Narita I
    Clin Exp Nephrol; 2018 Aug; 22(4):789-796. PubMed ID: 29181658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels.
    Yuan Q; Sitara D; Sato T; Densmore M; Saito H; Schüler C; Erben RG; Lanske B
    Endocrinology; 2011 Nov; 152(11):4053-61. PubMed ID: 21896668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.